Development and validation of a disease-
โ
Brennan M. R. Spiegel; Roger Bolus; Steven Han; Myron Tong; Eric Esrailian; Jenn
๐
Article
๐
2007
๐
John Wiley and Sons
๐
English
โ 130 KB
๐ 1 views
Despite the increasing realization that health-related quality of life (HRQOL) is an important outcome in chronic HBV infection, there are no validated, disease-targeted instruments currently available. We sought to develop and validate the first disease-targeted HRQOL instrument in noncirrhotic HBV